MedTrace Logo

TTFields in General Routine Clinical Care in Patients With Pleural Mesothelioma Study

NCT05538806 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 198

Last updated 2025-08-22

No results posted yet for this study

Summary

The purpose of this post-authorisation medical device study is to obtain real life data on the use of Tumor Treating Fields (TTFields) in patients with pleural mesothelioma in routine clinical care. Patients with pleural mesothelioma and clinical indication for TTFields treatment will be enrolled in the study after signing Informed consent to use their data and process it centrally for research purposes. The clinical indication for TTFields is one of the inclusion criteria and is defined prior to inclusion by the treating physician.

Conditions

  • Pleural Mesothelioma

Interventions

DEVICE

TTFields

all patients will receive routine clinical care and TTFields

Sponsors & Collaborators

  • NovoCure Ltd.

    lead INDUSTRY

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2023-08-01
Primary Completion
2027-12-31
Completion
2028-06-30

Countries

  • Germany
  • Italy
  • Netherlands

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05538806 on ClinicalTrials.gov